Advanced solutions to further oncology and immuno-oncology therapeutics development.


With the advent of immuno-oncology therapies including CAR-T cell therapies, therapeutic vaccines, tumour targeting mAbs, oncolytic viruses and immune checkpoint inhibitors, the landscape of oncology has been revolutionised. However, the complex interactions between the immune system and cancer necessitates comprehensive bioanalysis strategies to monitor and understand their effects.